跳至主要内容
临床试验/NCT03087500
NCT03087500撤回不适用

Physiologic Biomarkers Within the Functional Spectrum of Down Syndrome

University of Arkansas0 个研究点开始时间: 2017年10月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
主要终点
Folate Receptor Alpha Autoantibody (FRAA)

研究概览

简要总结

The overall goal of this study is to evaluate biomarkers of oxidative stress, mitochondrial function, and DNA methylation (epigenetics) in order to determine the extent to which these biomarkers are related to cognitive, behavioral and adaptive function in Down Syndrome. The inter-relationship between measurable biomarkers and functional/cognitive abilities will move beyond genetics to provide unprecedented new knowledge and a broader understanding of the underlying pathophysiology and abnormal gene expression induced by trisomy 21.

详细描述

The Investigators preliminary evidence indicates that people with DS have metabolic biomarkers associated with oxidative stress (GSH/GSSG) and reduced methylation capacity (SAM/SAH) as well as abnormal DNA methylation (epigenetics). The investigative team hypothesize that these abnormal metabolic processes contribute to abnormalities in behavior and development associated with trisomy 21; this connection has never been investigated. Confirming and expanding on the preliminary data would provide new understanding of the biological and functional etiology of the behavioral and developmental delays associated with Trisomy 21. Further, establishing the underlying relationship between metabolic abnormalities and behavioral/cognitive function over the age spectrum can provide strong support for the design of future treatments of individuals with DS aimed at improving their behavior and development. In addition, these biomarkers may also prove to be predictive biomarkers for the risk of developing ASD like behaviors or Alzheimer's disease in this population. Finally, examining the modulating role of diet in the severity of biological abnormalities will provide new information for lifestyle guidance to improve biomarkers and potentially minimize the medical co-morbidities associated with trisomy 21.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
3 Years 至 50 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Participant or guardian ability to consent/assent and willing to comply with protocol requirements

排除标准

  • Trisomy translocation or mosaics.
  • Untreated hypothyroidism
  • Known history of liver disease, renal disease, Hepatitis B or C or HIV
  • Recent infection with fever or requiring hospitalization within past 30 days.
  • Any medical condition, use of medications, nutrient or herbal supplements that would interfere with the study results as determined by the PI
  • Chemotherapy
  • Recent surgery (within 2 months)
  • Untreated Epilepsy
  • Any chronic medical/behavioral condition and/or treatments that may interfere with study related outcomes, as determined by PI
  • History of a significant adverse reaction to a prior blood draw
  • Any other historical event/information that may, in the opinion of the PI, be a reason to exclude the child from participation.

结局指标

主要结局

Folate Receptor Alpha Autoantibody (FRAA)

时间窗: 2 years

Serum will be collected for FRAA analysis on cases and controls

Thyroid Function

时间窗: 2 years

Thyroid measures of Thyroid Stimulating Hormone (TSH), T3, Reverse T3 and free and total T4 will be evaluated on cases and controls

Diet

时间窗: 2 years

Examine the modulating role of diet in the severity of biological abnormalities will provide new information for lifestyle guidance to improve biomarkers and potentially minimize the medical co-morbidities associated with trisomy 21. Dietary contributions will be evaluated on cases and controls

Mitochondrial Function Analysis

时间窗: 2 years

The Seahorse XR extracellular flux analyzer will be used to measure mitochondrial function in cases and controls

Metabolomics

时间窗: 2 years

Urine will be collected for metabolomics analysis on cases and controls

Microbiome Analysis

时间窗: 2 years

Stool will be collected for Microbiome Analysis on cases and controls

Immune Function

时间窗: 2 years

Salivary measurements of cytokines will be collected on cases and controls

Epigenetics

时间窗: 2 years

Epigenetics will be evaluated on cases and controls

Oxidative Stress Analysis

时间窗: 2 years

Thiol measurements will be collected and analyzed between cases and controls

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验